CD8A and neoplasm: According to the tumor-immunity cycle, PD-1+ tumor-reactive CD8 T cells are initially primed in tumor-draining lymph nodes (TDLNs) by antigens, migrate through the bloodstream to the tumor, and undergo further differentiation (55).